EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

RNF114-PACSIN3 signaling axis promotes hepatocellular carcinoma progression by enhancing GLUT1 membrane retention and glucose uptake

Yue Song, Yilu Lu, Qixiang Liu, Lan Yin, Wen Zheng, Ge Liang, Xinyi Hu, Xinyu Lin, You Zhang, Yongxin Ma

Cellular Oncology · 2026

DOI: 10.1007/s13402-026-01259-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, 2026. Verfasst von Yue Song und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Frontiers Science Center for Disease-related Molecular Networks, West China Hospital, Sichuan University, Chengdu, Si…. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Glucose Transporter Type 1, Signal Transduction. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Sichuan Provincial Science and Technology Support Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularGlucose Transporter Type 1Signal TransductionGlucoseDisease ProgressionCell MembraneAdaptor Proteins, Signal TransducingUbiquitin-Protein LigasesHumansAnimalsCell Line, TumorCell ProliferationMice, NudeSorafenibCell MovementMiceMaleUbiquitinationMice, Inbred BALB CDrug Resistance, NeoplasmGlycolysisXenograft Model Antitumor Assays

Stichwörter der Autor:innen

EndocytosisGLUT1GlycolysisRNF114Sorafenib resistance

Substanzen

Glucose Transporter Type 1GlucoseSorafenibSLC2A1 protein, humanAdaptor Proteins, Signal TransducingUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • Department of Medical Genetics, Frontiers Science Center for Disease-related Molecular Networks, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Metabolomics and Proteomics Platform, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Department of Medical Genetics, Frontiers Science Center for Disease-related Molecular Networks, West China Hospital, Sichuan University, Chengdu, Sichuan, China. mayx@scu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Sichuan Provincial Science and Technology Support Program

Zitieren

APA

Song, Y., Lu, Y., Liu, Q., Yin, L., Zheng, W., Liang, G., Hu, X., Lin, X., Zhang, Y., & Ma, Y. (2026). RNF114-PACSIN3 signaling axis promotes hepatocellular carcinoma progression by enhancing GLUT1 membrane retention and glucose uptake. Cellular Oncology. https://doi.org/10.1007/s13402-026-01259-6

Vancouver

Song Y, Lu Y, Liu Q, Yin L, Zheng W, Liang G, et al. RNF114-PACSIN3 signaling axis promotes hepatocellular carcinoma progression by enhancing GLUT1 membrane retention and glucose uptake. Cellular Oncology. 2026. doi:10.1007/s13402-026-01259-6

BibTeX
@article{Song2026,
  author = {Song, Yue and Lu, Yilu and Liu, Qixiang and Yin, Lan and Zheng, Wen and Liang, Ge and Hu, Xinyi and Lin, Xinyu and Zhang, You and Ma, Yongxin},
  title = {RNF114-PACSIN3 signaling axis promotes hepatocellular carcinoma progression by enhancing GLUT1 membrane retention and glucose uptake},
  journal = {Cellular Oncology},
  year = {2026},
  doi = {10.1007/s13402-026-01259-6}
}
Kostenlos starten →